Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia

Brain Research

Volumn 816, Issue 2, 1999, Pages 471-479

  Schmid Elsaesser, Robert ^a   Hungerhuber, Edwin ^a   Zausinger, Stefan ^a   Baethmann, Alexander ^a   Reulen, Hanns Juergen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

21 Aminosteroid; Antioxidant; Ischemia reperfusion; Neuroprotection; Oxygen free radical; Pyrrolopyrimidine

Indexed keywords

2,4 DIAMINOPYRROLOPYRIMIDINE; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; PYRROLOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CEREBRAL INFARCTION; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; ISCHEMIC ATTACK, TRANSIENT; LASER-DOPPLER FLOWMETRY; MALE; NEUROPROTECTIVE AGENTS; PREGNATRIENES; PYRIMIDINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033596556     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01197-4     Document Type: Article

References (82)

1. Audus K.L., Guillot F.L., Braughler J.M. Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radic. Biol. Med. 11:1991;361-371.
2. Avendano C., Roda J.M., Carceller F., Dieztejedor E. Morphometric study of focal cerebral ischemia in rats: a stereological evaluation. Brain Res. 673:1995;83-92.
3. Baskaya M.K., Hu Y.G., Donaldson D., Maley M., Rao A.M., Prasad M.R., Dempsey R.J. Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia. J. Neurosurg. 85:1996;112-116.
4. Beetsch J.W., Park T.S., Dugan L.L., Shah A.R., Gidday J.M. Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells. Brain Res. 786:1998;89-95.
5. Betz A.L., Randall J., Martz D. Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia. Am. J. Physiol. 260:1991;H563-H568.
6. Braughler J.M., Hall E.D. Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6:1989;289-301.
7. Braughler J.M., Hall E.D., Jacobsen E.J., McCall J.M., Means E.D. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future. 14:1989;143-152.
8. Cao X.H., Phillis J.W. Alpha-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644:1994;267-272.
9. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
10. Clemens J.A., Panetta J.A. Neuroprotection by antioxidants in models of global and focal ischemia. Ann. N.Y. Acad. Sci. 738:1994;250-256.
11. Corbett D., Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog. Neurobiol. 54:1998;531-548.
12. de la Torre J.C. Synergic activity of combined prostacyclin: dimethyl sulfoxide in experimental brain ischemia. Can. J. Physiol. Pharmacol. 69:1991;191-198.
13. Dirnagl U., Lindauer U., Them A., Schreiber S., Pfister H.W., Koedel U., Reszka R., Freyer D., Villringer A. Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J. Cereb. Blood Flow Metab. 15:1995;929-940.
14. +: implications for neurodegeneration. J. Neurochem. 63:1994;584-591.
15. Dyker A.G., Lees K.R. Duration of neuroprotective treatment for ischemic stroke. Stroke. 29:1998;535-542.
16. Fici G.J., Althaus J.S., Vonvoigtlander P.F. Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity. Free Radic. Biol. Med. 22:1997;223-228.
17. Folbergrova J., Zhao Q., Katsura K., Siesjö B.K. N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. USA. 92:1995;5057-5061.
18. Forsman M., Fleischer J.E., Milde J.H., Steen P.A., Michenfelder J.D. Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol. Scand. 32:1988;152-155.
19. Fukuyama N., Takizawa S., Ishida H., Hoshiai K., Shinohara Y., Nakazawa H. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J. Cereb. Blood Flow Metab. 18:1998;123-129.
20. Ginsberg M.D. Neuroprotection in brain ischemia: an update (Part II). Neuroscientist. 1:1995;164-175.
21. Globus M.Y.T., Busto R., Lin B.W., Schnippering H., Ginsberg M.D. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J. Neurochem. 65:1995;1250-1256.
22. Grammas P., Liu G.J., Wood K., Floyd R.A. Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels. Free Radic. Biol. Med. 14:1993;553-557.
23. Green A.R., Cross A.J. Techniques for examining neuroprotective drugs in vivo. Int. Rev. Neurobiol. 40:1997;47-68.
24. Hall E.D., Andrus P.K., Smith S.L., Fleck T.J., Scherch H.M., Lutzke B.S., Sawada G.A., Althaus J.S., Vonvoigtlander P.F., Padbury G.E., Larson P.G., Palmer J.R., Bundy G.L. Pyrrolopyrimidines: novel brain penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. J. Pharmacol. Exp. Ther. 281:1997;895-904.
25. Hall E.D., Andrus P.K., Smith S.L., Oostveen J.A., Scherch H.M., Lutzke B.S., Raub T.J., Sawada G.A., Palmer J.R., Banitt L.S., Tustin J.S., Belonga K.L., Ayer D.E., Bundy G.L. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir. Suppl. Wien. 66:1996;107-113.
26. Hall E.D., McCall J.M., Means E.D. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28:1994;221-268.
27. Hall E.D., Pazara K.E., Braughler J.M. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils. Stroke. 22:1991;361-366.
28. Hall E.D., Yonkers P.A. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke. 19:1988;340-344.
29. Haun S.E., Kirsch J.R., Helfaer M.A., Kubos K.L., Traystman R.J. Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets. Stroke. 22:1991;655-659.
30. Helfaer M.A., Kirsch J.R., Haun S.E., Moore L.E., Traystman R.J. Polyethylene glycol-conjugated superoxide dismutase fails to blunt postischemic reactive hyperemia. Am. J. Physiol. 261:1991;H548-H553.
31. Hunter A.J., Mackay K.B., Rogers D.C. To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends Pharmacol. Sci. 19:1998;59-66.
32. Imaizumi S., Woolworth V., Fishman R.A., Chan P.H. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke. 21:1990;1312-1317.
33. Inanami O., Kuwabara M. α-Phenyl N-tert-butyl nitrone (PBN) increases the cortical cerebral blood flow by inhibiting the breakdown of nitric oxide in anesthetized rats. Free Radic. Res. 23:1995;33-39.
34. Karlsson B.R., Loberg E.M., Grogaard B., Steen P.A. The antioxidant tirilazad does not affect cerebral blood flow or histopathologic changes following severe ischemia in rats. Acta Neurol. Scand. 90:1994;256-262.
35. Keller J.N., Kindy M.S., Holtsberg F.W., StClair D.K., Yen H.C., Germeyer A., Steiner S.M., BruceKeller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
36. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke. 8:1986;1-8.
37. Kontos C.D., Wei E.P., Williams J.I., Kontos H.A., Povlishock J.T. Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. Am. J. Physiol. 263:1992;H1234-H1242.
38. Kontos H.A., Wei E.P., Ellis E.F., Jenkins L.W., Povlishock J.T., Rowe G.T., Hess M.L. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ. Res. 57:1985;142-151.
39. Koroshetz W.J., Moskowitz M.A. Emerging treatments for stroke in humans. Trends Pharmacol. Sci. 17:1996;227-233.
40. Kristian T., Siesjö B.K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
41. Kumar M., Liu G.J., Floyd R.A., Grammas P. Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals. Biochem. Biophys. Res. Commun. 219:1996;497-501.
42. Kuroda S., Siesjö B.K. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin. Neurosci. 4:1997;199-212.
43. Lee S.H., Kondoh T., Camarata P.J., Heros R.C. Therapeutic time window for the 21-aminosteroid, U-74389G, in global cerebral ischemia. Neurosurgery. 38:1996;517-521.
44. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
45. Luo Z., Harada T., London S., Gajdusek C., Mayberg M.R. Antioxidant and iron-chelating agents in cerebral vasospasm. Neurosurgery. 37:1995;1154-1158.
46. Macdonald R.L., Bassiouny M., Johns L., Sajdak M., Marton L.S., Weir B.K., Hall E.D., Andrus P.K. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs. Neurosurgery. 42:1998;1339-1345.
47. Marion D.W., White M.J. Treatment of experimental brain injury with moderate hypothermia and 21-aminosteroids. J. Neurotrauma. 13:1996;139-147.
48. Martz D., Beer M., Betz A.L. Dimethylthiourea reduces ischemic brain edema without affecting cerebral blood flow. J. Cereb. Blood Flow Metab. 10:1990;352-357.
49. Martz D., Rayos G., Schielke G.P., Betz A.L. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke. 20:1989;488-494.
50. Maruki Y., Koehler R.C., Kirsch J.R., Blizzard K.K., Traystman R.J. Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia. J. Cereb. Blood Flow Metab. 15:1995;88-96.
51. Matsumiya N., Koehler R.C., Kirsch J.R., Traystman R.J. Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke. 22:1991;1193-1200.
52. Memezawa H., Zhao Q., Smith M.L., Siesjö B.K. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res. 670:1995;48-52.
53. Morimoto T., Globus M.Y., Busto R., Martinez E., Ginsberg M.D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;92-99.
54. Murakami K., Kondo T., Kawase M., Li Y.B., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18:1998;205-213.
55. Müller T.B., Haraldseth O., Jones R.A., Sebastiani G., Lindboe C.F., Unsgard G., Oksendal A.N. Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke. 26:1995;1453-1458.
56. Nakai A., Kuroda S., Kristian A., Siesjö B.K. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat. Neurobiol. Dis. 4:1997;288-300.
57. Oostveen J.A., Dunn E., Carter D.B., Hall E.D. Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model. J. Cereb. Blood Flow Metab. 18:1998;539-547.
58. Pellegrini-Giampietro D.E. Free radicals and the pathogenesis of neuronal death: cooperative role of excitatory amino acids. Adv. Exp. Med. Biol. 366:1994;59-71.
59. Peters O., Back T., Lindauer U., Busch C., Megow D., Dreier J., Dirnagl U. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18:1998;196-205.
60. Peterson P.L., Xiong X., Muizelaar J.P., Lee C.P. Protective effect of U-101033E or rat brain mitochondrial function following traumatic brain injury. J. Neurosurg. 86:1997;375A. Abstract.
61. Piantadosi C.A., Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 27:1996;327-331.
62. Raub T.J., Barsuhn C.L., Williams L.R., Decker D.E., Sawada G.A., Ho N.F. Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J. Drug Target. 1:1993;269-286.
63. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., Reulen H.J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage by laser Doppler flowmetry. Stroke. 29:1998;2162-2170.
64. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Plesnila N., Baethmann A., Reulen H.J. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia. Stroke. 28:1997;2018-2024.
65. Schulz J.B., Panahian N., Chen Y.I., Beal M.F., Moskowitz M.A., Rosen B.R., Jenkins B.G. Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniques. Am. J. Physiol. 272:1997;H1986-H1995.
66. Schürer L., Grogaard B., Gerdin B., Arfors K.E. Effects of neutrophil depletion and superoxide dismutase on postischemic hypoperfusion of rat brain. Adv. Neurol. 52:1990;57-62.
67. Schürer L., Grogaard B., Gerdin B., Arfors K.E. Superoxide dismutase does not prevent delayed hypoperfusion after incomplete cerebral ischaemia in the rat. Acta Neurochir. Wien. 103:1990;163-170.
68. Siesjö B.K., Agardh C.D., Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:1989;165-211.
69. Siesjö B.K., Zhao Q., Pahlmark K., Siesjö P., Katsura K., Folbergrova J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. Thorac. Surg. 59:1995;1316-1320.
70. Soehle M., Heimann A., Kempski O. Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats. Stroke. 29:1998;1240-1246.
71. Solenski N.J., Kwan A.L., Yanamoto H., Bennett J.P., Kassell N.F., Lee K.S. Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke. 28:1997;2545-2551.
72. Soloniuk D.S., Perkins E., Wilson J.R. Use of allopurinol and deferoxamine in cellular protection during ischemia. Surg. Neurol. 38:1992;110-113.
73. Takeda Y., Hashimoto H., Kosaka F., Hirakawa M., Inoue M. Albumin-binding superoxide dismutase with a prolonged half-life reduces reperfusion brain injury. Am. J. Physiol. 264:1993;H1708-H1715.
74. Tayarani I., Chaudiere J., Lefauconnier J.M., Bourre J.M. Enzymatic protection against peroxidative damage in isolated brain capillaries. J. Neurochem. 48:1987;1399-1402.
75. Toyoda T., Lee K.S. Differential induction of superoxide dismutase in core and penumbra regions after transient focal ischemia in the rat neocortex. Neurosci. Lett. 235:1997;29-32.
76. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195.
77. Villa R.F., Gorini A. Pharmacology of lazaroids and brain energy metabolism: a review. Pharmacol. Rev. 49:1997;99-136.
78. Wengenack T.M., Curran G.L., Olson E.E., Poduslo J.F. Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood-nerve and blood-brain barriers. Brain Res. 767:1997;128-135.
79. Wengenack T.M., Curran G.L., Poduslo J.F. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res. 754:1997;46-54.
80. Xue D., Slivka A., Buchan A.M. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke. 23:1992;894-899.
81. Yang G.Y., Chan P.H., Chen J., Carlson E., Chen S.F., Epstein P., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.
82. Zhao Q., Memezawa H., Smith M.L., Siesjö B.K. Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res. 649:1994;253-259.